Neurogene Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $191.2M | $192.6M |
| FY2021 | — | $-91.9M | $142.5M |
| FY2022 | — | $-145.7M | $82.0M |
| FY2023 | — | $186.0M | $148.2M |
| FY2024 | — | $310.4M | $136.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $191.2M | $192.6M |
| FY2021 | — | $-91.9M | $142.5M |
| FY2022 | — | $-145.7M | $82.0M |
| FY2023 | — | $186.0M | $148.2M |
| FY2024 | — | $310.4M | $136.6M |